ACCURAY INCORPORATED Foreign Currency Transaction Gain (Loss), before Tax
ACCURAY INCORPORATED (ARAY) reported Foreign Currency Transaction Gain (Loss), before Tax of $5.50 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-27
- ACCURAY INCORPORATED foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was $2.67M, a 945.10% increase year-over-year.
- ACCURAY INCORPORATED foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was $2.62M.
- ACCURAY INCORPORATED foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was $403.00K, a 127.68% increase year-over-year.
- ACCURAY INCORPORATED foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was -$195.00K, a 108.97% decline year-over-year.
- ACCURAY INCORPORATED foreign currency transaction gain (loss), before tax for fiscal 2026 was $5.50M, a 249.40% increase from fiscal 2025.
- ACCURAY INCORPORATED foreign currency transaction gain (loss), before tax for fiscal 2025 was $1.57M.
- ACCURAY INCORPORATED foreign currency transaction gain (loss), before tax for fiscal 2024 was -$2.05M.
- ACCURAY INCORPORATED foreign currency transaction gain (loss), before tax for fiscal 2023 was -$878.00K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 3 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month as first filed | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $5.29M derived: sum of 2 quarters · filed 2026-08-27 | $5.69M derived: sum of 3 quarters · filed 2026-08-27 | $5.50M 10-K · filed 2026-08-27 | ||
| 2026-03-31 | $2.62M 10-Q · filed 2026-05-06 | $3.03M derived: sum of 2 quarters · filed 2026-05-06 | $2.83M 10-Q · filed 2026-05-06 | $3.09M derived: sum of 4 quarters · filed 2026-08-27 | ||
| 2025-12-31 | $403.00K 10-Q · filed 2026-02-17 | $208.00K 10-Q · filed 2026-02-17 | $463.00K derived: sum of 3 quarters · filed 2026-08-27 | -$570.00K derived: sum of 4 quarters · filed 2026-08-27 | ||
| 2025-09-30 | -$195.00K 10-Q/A · filed 2026-02-17 | $60.00K derived: sum of 2 quarters · filed 2026-08-27 | -$973.00K derived: sum of 3 quarters · filed 2026-08-27 | -$796.00K derived: sum of 4 quarters · filed 2026-08-27 | ||
| 2025-06-30 | $255.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | -$778.00K derived: sum of 2 quarters · filed 2026-08-27 | -$601.00K derived: sum of 3 quarters · filed 2026-08-27 | $1.57M 10-K · filed 2026-08-27 | ||
| 2025-03-31 | -$1.03M 10-Q · filed 2026-05-06 | -$856.00K derived: sum of 2 quarters · filed 2026-05-06 | $1.32M 10-Q · filed 2026-05-06 | $642.00K derived: sum of 4 quarters · filed 2026-05-06 | ||
| 2024-12-31 | $177.00K 10-Q · filed 2026-02-17 | $2.35M 10-Q · filed 2026-02-17 | $1.68M derived: sum of 3 quarters · filed 2026-02-17 | $2.54M derived: sum of 4 quarters · filed 2026-02-17 | ||
| 2024-09-30 | $2.17M 10-Q/A · filed 2026-02-17 | $1.50M derived: sum of 2 quarters · filed 2026-02-17 | $2.36M derived: sum of 3 quarters · filed 2026-02-17 | $1.08M derived: sum of 4 quarters · filed 2026-02-17 | ||
| 2024-06-30 | -$676.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-02-17 | $188.00K derived: sum of 2 quarters · filed 2026-02-17 | -$1.09M derived: sum of 3 quarters · filed 2026-02-17 | -$2.05M 10-K/A · filed 2026-02-17 | ||
| 2024-03-31 | $864.00K 10-Q · filed 2025-05-02 | $861.00K 10-Q · filed 2024-05-08 | -$414.00K derived: sum of 2 quarters · filed 2025-05-02 | -$1.37M 10-Q · filed 2025-05-02 | -$1.37M 10-Q · filed 2024-05-08 | -$1.72M derived: sum of 4 quarters · filed 2025-05-02 |
| 2023-12-31 | -$1.28M 10-Q · filed 2025-02-05 | -$2.23M 10-Q · filed 2025-02-05 | -$2.58M derived: sum of 3 quarters · filed 2025-02-05 | -$2.83M derived: sum of 4 quarters · filed 2025-02-05 | ||
| 2023-09-30 | -$956.00K 10-Q · filed 2024-11-06 | -$1.31M derived: sum of 2 quarters · filed 2024-11-06 | -$1.55M derived: sum of 3 quarters · filed 2024-11-06 | |||
| 2023-06-30 | -$350.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-19 | -$594.00K derived: sum of 2 quarters · filed 2024-09-19 | -$878.00K 10-K · filed 2024-09-19 | |||
| 2023-03-31 | -$244.00K 10-Q · filed 2024-05-08 | -$528.00K 10-Q · filed 2024-05-08 | ||||
| 2022-06-30 | -$2.62M 10-K · filed 2024-09-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |